About Conference
The 13th International Conference on Gynecology and Obstetrics, scheduled for March 13-14, 2025, in Prague, Czech Republic, revolving around the theme “The Future of Women's Health: Emerging Trends and Technologies” . This prestigious event aims to bring together leading experts, researchers, and clinicians from around the world to share the latest advancements and research in the field of gynecology and obstetrics. Euro Gynecology Congress 2025 will provide a comprehensive platform for professionals to discuss cutting-edge developments in areas such as reproductive endocrinology, gynecologic oncology, maternal-foetal medicine, and minimally invasive surgery. Attendees will have the opportunity to engage in dynamic discussions, attend insightful presentations, and participate in hands-on workshops designed to enhance clinical skills and improve patient outcomes. The conference will also feature keynote speeches from renowned specialists, offering valuable insights into the future of women's health. This gathering promises to be an invaluable experience for all participants, fostering collaboration and innovation in gynecology and obstetrics.
Target Audience:
-
Gynecologists
-
Obstetricians
-
Gynaecologic-Oncologists
-
Sexologists
-
Scientists and professors
-
Pediatric Gynaecologist
-
Breast Cancer surgeons, pathologists
-
Nurses/ Neonatologists
-
Medical Students and researchers
-
Gynecology surgeons, pathologist
-
Healthcare Associations and Societies
Sessions and Tracks
Track 1: Reproductive Endocrinology
Reproductive endocrinology is a subspecialty of obstetrics and gynaecology that focuses on the diagnosis and treatment of hormonal disorders related to reproduction and infertility. Reproductive endocrinology plays a critical role in helping individuals and couples achieve their reproductive goals, manage reproductive health issues, and improve their overall quality of life. By addressing hormonal imbalances and reproductive disorders, reproductive endocrinologists contribute to advancements in fertility treatments, reproductive health, and personalized patient care.
-
Hormonal Regulation and Reproductive Cycles
-
Endocrine Disorders Affecting Reproduction
-
Genetic and Congenital Disorders
Track 2: Gynaecologic oncology
Gynaecologic oncology is a specialized field of medicine that focuses on diagnosing and treating cancers of the female reproductive system. This includes cancers of the ovaries, fallopian tubes, uterus, cervix, vagina, and vulva. Gynaecologic oncologists are physicians who receive advanced training in both gynaecology and oncology to provide comprehensive care for women with these cancers.
Track 4: Advanced Laparoscopic and Robotic Surgery in Gynecology
Advanced laparoscopic and robotic surgery in gynecology represents a significant leap forward in minimally invasive surgical techniques. These approaches offer numerous benefits, including reduced pain, shorter hospital stays, faster recovery times, and improved surgical precision. Advanced laparoscopic and robotic surgery in gynecology represents a transformative approach to surgical care, offering numerous benefits over traditional open surgery. Continued innovation, training, and research are essential to further enhance these techniques and improve patient outcomes in the field of gynecology.
Track 5: Maternal-Fetal Medicine (MFM)
Maternal-Fetal Medicine (MFM) is a specialized field within obstetrics dedicated to the management of high-risk pregnancies. This discipline encompasses the care of both the mother and fetus, addressing complex medical, surgical, obstetrical, fetal, and genetic issues that may arise during pregnancy. MFM specialists, also known as perinatologists, possess advanced training and expertise in handling high-risk pregnancy conditions such as preeclampsia, gestational diabetes, preterm labor, multiple gestations, and fetal abnormalities. These professionals collaborate closely with obstetricians, neonatologists, and other healthcare providers to ensure optimal outcomes for both mother and child. Utilizing advanced diagnostic techniques, including ultrasound, fetal echocardiography, and genetic testing, MFM specialists deliver comprehensive care tailored to the unique needs of each patient.
Track 6: Urogynecology and Pelvic Floor Disorders
Urogynecology is a subspecialty of gynecology that focuses on the diagnosis and treatment of pelvic floor disorders in women. Common pelvic floor disorders include urinary incontinence, pelvic organ prolapse, fecal incontinence, and pelvic pain. Urogynecologists are physicians with specialized training in both gynecology and urology, enabling them to provide comprehensive care for conditions affecting the female pelvic organs. They employ a range of diagnostic techniques, including pelvic exams, urodynamic testing, and imaging studies, to accurately identify the underlying causes of pelvic floor dysfunction. Treatment options for pelvic floor disorders may include lifestyle modifications, pelvic floor physical therapy, medications, minimally invasive procedures, and surgical interventions.
-
Pelvic Organ Prolapse: Diagnosis and Management
-
Urinary Incontinence: Latest Treatments
-
Pelvic Floor Rehabilitation Techniques
Track 7: Menopause and Hormone Replacement Therapy
Menopause is a natural biological process that signifies the end of a woman's reproductive years. This transition is accompanied by a decline in the production of estrogen and progesterone, leading to various physical and emotional symptoms, including hot flashes, night sweats, mood swings, vaginal dryness, and sleep disturbances. Hormone Replacement Therapy (HRT) is a treatment used to alleviate menopausal symptoms by replenishing the hormones that the body no longer produces. HRT can involve the administration of estrogen alone or a combination of estrogen and progesterone. There are various forms of HRT, including oral tablets, skin patches, gels, creams, and vaginal rings. Additionally, lifestyle changes such as a healthy diet, regular exercise, and stress management can complement HRT and help manage menopausal symptoms .By providing personalized care and addressing the unique needs of each woman, healthcare providers aim to improve the quality of life during menopause and beyond.
Track 8: Gynecologic surgery
Gynecologic surgery includes a variety of procedures conducted on the female reproductive system to address a range of conditions, diseases, and disorders. These surgeries target issues affecting the uterus, ovaries, fallopian tubes, cervix, and vagina. They may be performed for diagnostic, therapeutic, or preventative reasons.
Track 9: Assisted Reproductive Technology (ART)
Assisted Reproductive Technology (ART) refers to medical procedures used to treat infertility and assist individuals and couples in achieving pregnancy. ART encompasses a variety of techniques that involve manipulating eggs, sperm, and embryos outside the body. These technologies have provided hope to many who struggle with infertility and have significantly advanced reproductive medicine. Success rates of ART vary based on factors such as the woman’s age, the cause of infertility, the type of ART used, and the specific fertility clinic. Generally, younger women have higher success rates, and advances in technology and techniques continue to improve outcomes.
-
In Vitro Fertilization (IVF)
-
Intracytoplasmic Sperm Injection (ICSI)
-
Gamete Intrafallopian Transfer (GIFT)
-
Zygote Intrafallopian Transfer (ZIFT)
Track 10: Obstetric anesthesia and pain management
Obstetric anesthesia and pain management are crucial components of prenatal care, labor, delivery, and the postpartum period. Effective pain management techniques not only improve the childbirth experience but also ensure the safety and comfort of both the mother and baby. Effective obstetric anesthesia and pain management are integral to ensuring a positive childbirth experience and optimal outcomes for both the mother and baby. By utilizing a combination of pharmacologic and non-pharmacologic methods, healthcare providers can tailor pain management to meet the individual needs and preferences of each patient.
-
Epidural Anesthesia
-
Spinal Anesthesia
-
Combined Spinal-Epidural (CSE) Anesthesia
Track 11: Gynecologic Diseases
Gynecologic diseases encompass a wide array of conditions affecting the female reproductive system, including the uterus, ovaries, fallopian tubes, cervix, and vagina. These diseases can significantly impact a woman's health, fertility, and overall quality of life. Early detection through regular screenings like Pap smears and pelvic exams, combined with preventive measures such as HPV vaccination and healthy lifestyle choices, is crucial. Treatment options vary widely, from medication and hormonal therapies to surgical interventions, tailored to manage symptoms and improve the quality of life for affected women.
Track 12: Innovations in gynecology
Innovations in gynecology are revolutionizing the field with ground-breaking advancements that enhance patient care and treatment outcomes. Artificial intelligence (AI) and machine learning are making significant strides in gynecology by enhancing diagnostic accuracy and treatment planning. AI algorithms are being employed to analyse imaging data and pathology slides, identifying patterns and anomalies that may be missed by the human eye. Predictive analytics tools leverage patient data to forecast disease risk and treatment outcomes, enabling more personalized and proactive care. They are offering new possibilities for treating reproductive disorders and repairing damaged tissues, further expanding the horizons of gynecological care.
Track 13: Adolescent Gynecology and Pediatric Gynecology
Adolescent gynecology and pediatric gynecology are specialized fields that address the unique reproductive health needs of young females, from infancy through adolescence. Adolescent gynecology focuses on the issues such as menstrual disorders, management of irregular or painful periods, contraception, and sexual health education and the prevention of sexually transmitted diseases (STDs). Pediatric gynecology addresses gynecological issues in children from infancy through early adolescence, congenital anomalies, developmental concerns, and pre-pubertal conditions. Pediatric gynecologists diagnose and manage congenital malformations of the reproductive organs, labial adhesions, vulvovaginitis, and trauma to the genital area. By offering specialized care and attention, adolescent and pediatric gynecology play crucial roles in promoting the reproductive health and overall well-being of young females, helping them navigate their developmental stages with confidence and knowledge.
Market Analysis
The global gynecological devices market
Gynecology and Obstetrics encompass a wide range of medical conditions related to women's reproductive systems. Changes in women's lifestyles have led to an increase in obstetric and gynecological disorders affecting the appendages, uterus, and ovaries. Several symptoms associated with gynecologic problems impact the female reproductive system, including vaginal tingling and discharge. A growing geriatric female population and revitalized economic growth are likely to contribute to the expansion of the obstetrics and gynecology drug market. Continuous research and development efforts in the pharmaceutical industry aim to develop more efficient and innovative drugs with enhanced healing effects, capable of addressing a broad spectrum of obstetric and gynecological diseases. The global gynecological devices market, valued at USD 10.52 billion in 2024, is anticipated to reach approximately USD 22 billion by 2033, growing at a CAGR of 8.50% from 2024 to 2033.
The global gynecology drugs market
The global gynecology drugs market reached a value of nearly $38,109.7 million in 2021, having grown at a compound annual growth rate (CAGR) of 3.1% since 2016. The market is expected to expand from $38,109.7 million in 2021 to $49,481.1 million by 2026, at a CAGR of 5.4%. Furthermore, the market is projected to grow at a CAGR of 5.6% from 2026, reaching $64,957.5 million by 2031.
Past Conference Report
The Euro Gynecology Congress 2024 emerged as a resounding success, marking a milestone in reproductive health education and collaboration. Several pivotal factors contributed to its triumph. The program's comprehensive scope and depth were instrumental, offering a diverse range of topics, sessions, and workshops tailored to the evolving needs of the female healthcare community. Esteemed speakers and thought leaders from around the globe graced the event, sharing invaluable insights that not only inspired but also enhanced attendees' knowledge. Interactive workshops and skill-building sessions provided hands-on learning experiences that resonated with both novice and seasoned gynecologists and obstetricians. Networking opportunities flourished, fostering connections that transcended geographical and disciplinary boundaries.
Significantly, post-conference resources extended the impact of the Euro Gynecology Congress 2024, delivering lasting value to attendees and the broader women’s healthcare community. The overwhelmingly positive feedback and testimonials from participants underscored the event's success, with many expressing satisfaction and appreciation for its enriching, informative, and inspiring nature. The Euro Gynecology Congress 2024 stands as a beacon of achievement, driving professional growth and serving as a catalyst for transformative change in gynecology and obstetrics.
As we celebrate the triumph of the Euro Gynecology Congress 2024, we eagerly anticipate building upon this foundation for the Euro Gynecology Congress 2025. The upcoming conference promises further opportunities for professional development, collaboration, and innovation in the fields of gynecology and obstetrics. We invite you to join us in Prague, Czech Republic, from March 13-14, 2025, as we collectively propel the field of gynecology and obstetrics to new heights. Stay tuned for more information, and prepare to embark on another remarkable journey in the realm of gynecology!